[Translation] A randomized, placebo-controlled, double-blind, phase I study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of DR10624 in single and multiple subcutaneous doses, dose escalation
在中国健康成人受试者、超重或肥胖受试者中评估DR10624单次皮下给药的安全性和耐受性。
[Translation] The safety and tolerability of a single subcutaneous administration of DR10624 was evaluated in Chinese healthy adult subjects, overweight or obese subjects.